- Home
- AVIR vs MIN Comparison
AVIR vs MIN Comparison
Compare AVIR & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | MIN |
|---|---|---|
| Founded | 2012 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.0M | 297.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | MIN |
|---|---|---|
| Price | $6.08 | $2.55 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 569.0K | 276.1K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.31% |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.46 | $2.50 |
| 52 Week High | $6.45 | $2.73 |
Technical Indicators
Market Signals| Indicator | AVIR | MIN |
|---|---|---|
| Relative Strength Index (RSI) | 76.99 | 45.03 |
| Support Level | $3.33 | N/A |
| Resistance Level | N/A | $2.61 |
| Average True Range (ATR) | 0.31 | 0.03 |
| MACD | 0.12 | -0.00 |
| Stochastic Oscillator | 79.43 | 50.00 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.